Loading...
Docoh
Log in Free sign up

Biolife Solutions (BLFS)

BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services. Its products and services portfolio includes its proprietary CryoStor® freeze media, HypoThermosol® shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, and Custom Biogenic Systems high capacity storage freezers and SciSafe biologic storage services.

Company profile

Ticker
BLFS
Exchange
NASDAQ
Website
www.biolifesolutions.com
CEO
Michael Rice
Employees
Incorporated
Delaware
Location
Washington
Fiscal year end
Dec 31
Sector
Manufacturing > Surgical and Medical Instrument Manufacturing
Industry (SIC)
Electromedical & Electrotherapeutic Apparatus
Medtronic • Varian Medical Systems • Conmed • Masimo • Natus Medical • LivaNova • Outset Medical • Fonar • Cutera • Inmode ...
Former names
CRYOMEDICAL SCIENCES INC
SEC CIK
0000834365
Corporate docs
Subsidiaries
SAVSU Technologies, Inc. • Arctic Solutions, Inc. • SciSafe Holdings, Inc. • Global Cooling, Inc. • Sexton Biotechnologies, Inc. • BioLife B.V. ...
IRS number
943076866

BLFS stock data

News

From Benzinga Pro
BioLife Solns: Q2 Earnings Insights
9 Aug 22
BioLife Solns (NASDAQ:BLFS) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
BioLife Solutions Q2 Sales $40.53M Beat $39.18M Estimate
9 Aug 22
BioLife Solutions (NASDAQ:BLFS) reported quarterly sales of $40.53 million which beat the analyst consensus estimate of $39.18 million by 3.45 percent. This is a 29.90 percent increase over sales of $31.20 million the
Earnings Scheduled For August 9, 2022
9 Aug 22
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
BioLife Solutions Deploys SciSafe's Ultra Low Controlled Temperature Trailers To Extend Domestic Cold Chain Services
9 Jun 22

Press releases

From Benzinga Pro
BioLife Solutions Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Revenue Guidance
9 Aug 22
Record revenue of $40.5 million increased 30% over Q2 2021, with organic revenue growth of 44% and biopreservation media revenue growth of 46% Updating 2022 revenue guidance to $160 million to $166 million, reflecting
BioLife Solutions to Report Second Quarter 2022 Financial Results and Provide Business Update on August 9, 2022
2 Aug 22
BOTHELL, Wash., Aug. 2, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader
BioLife Solutions Deploys SciSafe's Ultra Low Controlled Temperature Trailers to Extend Domestic Cold Chain Services
9 Jun 22
The new service will enable life sciences companies to seamlessly move hardware as well as biomaterials at the local level BOTHELL, Wash., June 9, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS), a leading

Calendar

10 May 22
12 Aug 22
31 Dec 22

Financial summary

Financial statements Chart BLFS financial data
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 59.5M 59.5M 59.5M 59.5M 59.5M 59.5M
Cash burn (monthly) 3.47M 2.46M 2.56M 3.4M 2.64M 1.19M
Cash used (since last report) 15.27M 10.83M 11.25M 14.96M 11.63M 5.26M
Cash remaining 44.23M 48.67M 48.25M 44.54M 47.87M 54.24M
Runway (months of cash) 12.8 19.8 18.9 13.1 18.1 45.4

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Recent insider trades

BLFS insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
10 Aug 22 Rice Michael Common Stock Sell Dispose S No No 23.17 171 3.96K 363,550
10 Aug 22 Sarah Aebersold Common Stock Sell Dispose S No No 23.17 40 926.8 32,401
10 Aug 22 Berard Todd Common Stock Sell Dispose S No No 23.17 52 1.2K 108,394
10 Aug 22 Aby J. Mathew Common Stock Sell Dispose S No No 23.17 112 2.6K 254,752
10 Aug 22 Karen A. Foster Common Stock Sell Dispose S No No 23.17 95 2.2K 109,394
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

BLFS institutional ownership history Ownership history
87.5% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 159 165 -3.6%
Opened positions 29 26 +11.5%
Closed positions 35 22 +59.1%
Increased positions 70 67 +4.5%
Reduced positions 41 51 -19.6%
13F shares Current Prev Q Change
Total value 910.03M 1.4B -35.2%
Total shares 37.1M 36.65M +1.2%
Total puts 48.9K 101.1K -51.6%
Total calls 7.2K 53.1K -86.4%
Total put/call ratio 6.8 1.9 +256.7%
Largest owners Shares Value Change
Casdin Capital 7.57M $171.98M 0.0%
BLK Blackrock 3.71M $84.39M +1.6%
Vanguard 2.2M $50.04M +2.5%
Villiger Walter 1.98M $111.97M 0.0%
Fred Alger Management 1.85M $42.08M +9.2%
Geneva Capital Management 1.46M $33.11M -2.2%
Ranger Investment Management 1.3M $29.56M +3.6%
Millennium Management 1.07M $24.4M +99.3%
AMP Ameriprise Financial 1.07M $24.37M -0.3%
STT State Street 1.01M $22.9M +9.0%
Largest transactions Shares Bought/sold Change
Millennium Management 1.07M +534.74K +99.3%
Marshall Wace 885.46K -461.29K -34.3%
Jennison Associates 422.34K -415.91K -49.6%
RMB Capital Management 324.98K +324.98K NEW
Stanley-Laman 0 -258.64K EXIT
Thrivent Financial For Lutherans 212.23K +188.38K +789.9%
Granahan Investment Management 609.6K +175.17K +40.3%
Fred Alger Management 1.85M +156K +9.2%
Two Sigma Investments 108.46K +108.46K NEW
BAC Bank Of America 437.32K -94.9K -17.8%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

?
Competition
CryoPort

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: Accumulated, added, Additionally, arose, biopharma, biorepository, borrower, conduct, currency, documentation, domestic, enforcement, estate, fourth, identification, inadequate, ineffective, journal, local, logical, metal, northeastern, ongoing, owed, paragraph, pattern, point, precautionary, precise, precision, prolonged, promised, proper, quantitative, recurrence, semiconductor, short, smart, standalone, translated, translation, troubled, twelve, ULT, unintentional, Vehicle, vi, Vintage, visibility
Removed: Aid, Albuquerque, amendment, American, anniversary, awarded, back, began, bioprocessing, Bothell, California, carryback, charitable, commencement, commencing, constitute, consumer, convertible, declared, deduction, deferment, deferring, Detroit, disease, diversify, doubtful, earned, electrical, employer, enabling, Enhancing, enter, equal, expanding, faced, facilitate, feet, foreseeable, healthcare, hedging, Hiring, impacted, Implementing, improvement, inappropriate, index, inform, initial, intended, involving, July, June, launch, liter, Menlo, methodology, Mexico, Michigan, minimum, modified, month, nature, obtain, Park, payroll, PPP, President, primary, proportionate, ranged, realized, recording, refundable, relating, renewal, repayable, Rescue, response, Retention, retrospective, ROU, schedule, security, Smaller, social, square, studying, substantial, Subtopic, supportable, tangible, tenant, tied, timely, transparency, treating, typically, unrealized, unsecured, Washington
From filing 10-Q 2022 Q1
Financial reports
View all
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
30 Mar 22
NT 10-K
Notice of late annual filing
2 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
10-Q
2021 Q2
Quarterly report
16 Aug 21
10-Q
2021 Q1
Quarterly report
17 May 21
10-K
2020 FY
Annual report
31 Mar 21
10-Q
2020 Q3
Quarterly report
9 Nov 20
10-Q
2020 Q2
Quarterly report
10 Aug 20
10-K/A
2019 FY
Annual report (amended)
18 Jun 20
Current reports
View all
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 22
8-K
BioLife Solutions Reports First Quarter 2022 Financial Results
9 May 22
8-K
Changes in Registrant's Certifying Accountant
7 Apr 22
8-K
BioLife Solutions Receives Nasdaq Notice of Noncompliance for Delayed 10-K Filing
18 Mar 22
8-K
BioLife Solutions Reports Unaudited Fourth Quarter and Full Year 2021 Financial Results
28 Feb 22
8-K
BioLife Solutions Announces Preliminary 2021 Revenue of $119 Million, Up 148% Over 2020
10 Jan 22
8-K
BioLife Solutions Announces Third Quarter 2021 Financial Results
12 Nov 21
8-K
BioLife Solutions Announces Executive Management Changes
9 Nov 21
8-K
Departure of Directors or Certain Officers
7 Oct 21
8-K
Departure of Directors or Certain Officers
17 Sep 21
Registration and prospectus
View all
S-3ASR
Automatic shelf registration
1 Sep 21
S-8
Registration of securities for employees
7 Jul 21
424B3
Prospectus supplement
19 May 21
424B5
Prospectus supplement for primary offering
6 Jul 20
424B5
Prospectus supplement for primary offering
1 Jul 20
S-3
Shelf registration
24 Sep 19
S-3/A
Shelf registration (amended)
20 Mar 18
S-3/A
Shelf registration (amended)
4 Feb 18
S-3
Shelf registration
4 Jan 18
S-8
Registration of securities for employees
4 Jan 18
Proxies
View all
DEF 14A
Definitive proxy
29 Apr 22
DEF 14A
Definitive proxy
30 Apr 21
DEF 14A
Definitive proxy
29 May 20
DEF 14A
Definitive proxy
30 Apr 19
DEF 14A
Definitive proxy
5 Apr 18
DEF 14A
Definitive proxy
13 Apr 17
DEF 14A
Definitive proxy
29 Mar 16
DEF 14A
Definitive proxy
23 Mar 15
DEFA14A
Additional proxy soliciting materials
23 Mar 15
DEF 14A
Definitive proxy
19 Jun 14
Other
View all
EFFECT
Notice of effectiveness
7 Oct 19
CORRESP
Correspondence with SEC
1 Oct 19
UPLOAD
Letter from SEC
1 Oct 19
EFFECT
Notice of effectiveness
10 Apr 18
CORRESP
Correspondence with SEC
9 Apr 18
UPLOAD
Letter from SEC
16 Dec 16
CORRESP
Correspondence with SEC
8 Dec 16
UPLOAD
Letter from SEC
16 Nov 16
EFFECT
Notice of effectiveness
14 Jan 16
CORRESP
Correspondence with SEC
11 Jan 16
Ownership
View all
4
BIOLIFE SOLUTIONS / Aby J. Mathew ownership change
11 Aug 22
4
BIOLIFE SOLUTIONS / Karen A. Foster ownership change
11 Aug 22
4
BIOLIFE SOLUTIONS / Marcus Schulz ownership change
11 Aug 22
4
BIOLIFE SOLUTIONS / Michael Rice ownership change
11 Aug 22
4
BIOLIFE SOLUTIONS / Sarah Aebersold ownership change
11 Aug 22
4
BIOLIFE SOLUTIONS / Todd Berard ownership change
11 Aug 22
4
BIOLIFE SOLUTIONS / Marcus Schulz ownership change
5 Aug 22
4
BIOLIFE SOLUTIONS / Aby J. Mathew ownership change
2 Aug 22
4
BIOLIFE SOLUTIONS / Amy DuRoss ownership change
2 Aug 22
4
BIOLIFE SOLUTIONS / Joseph C Schick ownership change
2 Aug 22

Patents

View all
Utility
Shaping Liquid Material In A Cryostorage Bag To Obtain Desired Solid Shape
27 Jan 22
Systems, devices and methods for shaping a liquid material within a cryostorage bag while undergoing a freezing procedure.
Utility
Cryogenic systems
25 Jan 22
Cryogenic devices are provided in which solid carbon dioxide (dry ice) is used to maintain a temperature zone in which samples can be manipulated under conditions in which the sample is maintained at a temperature below −50° C.
Utility
Shock Absorbing Device to Protect Cryopreserved Biological Material
14 Oct 21
A shock absorbing device to protect cryogenically frozen biological material includes an outer sleeve and a foam sleeve.
Utility
Shock Absorbing Container to Protect Cryopreserved Biological Material
14 Oct 21
A shock absorbing container to protect cryogenically frozen biological material includes an outer case, which includes a first outer panel and a second outer panel, the first outer panel and the second outer panel movable relative to each other between a closed position and an open position, the first outer panel and the second outer panel defining a storage space in the closed position, the first outer panel having a first side facing the storage space, the second outer panel having a first side facing the storage space, wherein moving the first outer panel and the second outer panel into the open position creates or enlarges an opening to access the storage space.
Utility
Systems, Devices, and Methods for Automated Sample Thawing
22 Jul 21
The present invention generally relates to thawing a cryogenically frozen sample.

Transcripts

View all
2022 Q2
Earnings call transcript
10 Aug 22
2022 Q1
Earnings call transcript
10 May 22
2021 Q4
Earnings call transcript
1 Mar 22
2021 Q3
Earnings call transcript
12 Nov 21
2021 Q2
Earnings call transcript
13 Aug 21
2021 Q1
Earnings call transcript
14 May 21
2020 Q4
Earnings call transcript
23 Mar 21
2020 Q3
Earnings call transcript
8 Nov 20
2020 Q2
Earnings call transcript
9 Aug 20
2020 Q1
Earnings call transcript
14 May 20

Reddit threads

View all